WHO: Evidence for transitioning children is ‘limited and variable’

The World Health Organisation (WHO) has pulled back from issuing guidelines recommending so-called “gender-affirming care” for children and adolescents experiencing gender dysphoria. This can include puberty blockers, sex hormones and surgery.

A just-released WHO FAQ Sheet on the “development of a guideline on the health of trans and gender diverse people said: “The scope [of the guidance] will cover adults only and not address the needs of children and adolescents, because on review, the evidence base for children and adolescents is limited and variable regarding the longer-term outcomes of gender affirming care for children and adolescents”.

Commenting on the move, Wesley J. Smith National Review said it shows that the science is not settled, and is in fact moving away from so-called “gender-affirming care” that uncritically moves a child along a path to sex-change, upon request.

He said that WHO had been preparing to push this model as the standard of care for treating dysphoric children, but after getting intense pushback, it backed down.

It also made a crucial admission that the evidence for that model of treatment simply isn’t there, contradicting what is public policy in some US states and in the Biden administration.